<DOC>
	<DOCNO>NCT00877409</DOCNO>
	<brief_summary>The objective study establish safety use topical drug Acnase Creme effectiveness treatment acne grade I ( comedo ) II ( comedo , papule , pustule ) .</brief_summary>
	<brief_title>Safety Efficacy Study Acnase Creme Treatment Acne Vulgaris I II</brief_title>
	<detailed_description>The acne common dermatosis dermatological practice , affect 80 % population second third decade life . It find worldwide , evidence racial ethnic difference influence susceptibility development . However influence genetic factor , hormone , use certain drug may previous aggravate disease . It inflammatory disease follicle polissebáceo , consist large sebaceous gland , multiacinares , rudimentary hair follicle channel comprise acro-infundibulum upper portion infra-infundibulum dermal portion . This benign condition , self-limited , cause serious psychological problem disfigure scar , persist rest life . The initial change disorder follicular epithelial differentiation , cornea cell ( keratinocytes ) follicle polissebáceo excessively release lumen . The result event appearance precursor , microcomedão , lesion acne develop ( closed comedo , open comedo , papule , pustule nodule ) . The dilation follicular infundibulum material produce corneal comedão close . This first clinically visible lesion acne . As hyperkeratosis extend upper infundibulum , extend opening , form comedão open . The pathogenesis acne complex understood part . The follicular occlusion adherent keratinocytes activation hormone secretion result formation sebaceous microcomedão . Studies suggest free fatty acid intrafoliculares control inflammation chemotactic property leukocytes , monocytes neutrophil . The free fatty acid may provide primary stimulus retention hyperkeratosis follicularis . Moreover , tallow provide favorable substrate proliferation Propiniobacterium acne ( P. acne ) . Studies suggest P. acne , microaerophilic bacterium ( almost anaerobic ) , Gram-positive , lipase able hydrolyze triglyceride sebum free fatty acid . Therefore , pathogen play critical role generation inflammatory lesion . The P. acne produce protease neuroaminidases , may increase permeability follicular epithelium . Also produce chemotactic factor low molecular weight selects polymorphonuclear leukocyte . In process phagocytosis bacteria release hydrolases , break integrity follicular wall . Subsequently , content intrafolicular - fragment keratin , fat , hair , P. acnes - expel dermis . If surface aggregation neutrophil , wheal , presence purulent secretion , pustule . With infiltration inflammation deep extensive , nodule cyst produce . Clinically , eruption acnéica locate predominantly face ( 90 % ) less extent , back ( 60 % ) chest ( 15 % ) . As young man , mainly affect face , old , back .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Age : 12 35 year ; Oily skin tendency acne ; Presence noninflammatory lesion inflammatory , acne vulgaris diagnose grade I II , follow : I ) Comedones comedo ; II ) Papulopustular comedo , papule pustule ; III ) Nodulocystic comedo , papule , pustule , nodule cyst ; IV ) Conglobates severe acne , usually affect area body , preference , give comedo , papule , pustule , abscess , confluent nodule , cyst scar . Agreement compliance procedure trial attend clinic certain day times medical evaluation score injury acne ; Signing Term Free Informed Consent agreement low case patient 12 17 year . Pregnancy ( pregnancy test urinary indication woman voluntary childbearing age ) ; Nursing ; Nodulocystic Conglobates acne ; Conditions associate hormone ( tireoid disease , micropolicysts ovary , adrenal pituitary disorder ) ; Drug use systemic corticosteroid , anticonvulsant , photosensibility / new drug 01 month selection ; Use topical therapy , systemic physical ( clean skin ) treatment acne least 01 month selection ; History atopic allergic skin ; History hypersensitivity Benzoyl peroxide sulfur ; Skin Conditions active ( / spread ) may interfere outcome study ; Beginning enduse contraceptive ; ( female ) Sunlight intense exposure 01 month assessment ; Aesthetic treatment , skin 01 month selection ; Use specific oily cosmetic skin / acne makeup , facial moisturizing , etc.. ; Use drug Acnase prior inclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Acnase</keyword>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
</DOC>